DK3004077T3 - Nye 3,4-dihydro-2H-isoquinolin-1-on- og 2,3-dihydro-isoindol-1-on-forbindelser - Google Patents

Nye 3,4-dihydro-2H-isoquinolin-1-on- og 2,3-dihydro-isoindol-1-on-forbindelser Download PDF

Info

Publication number
DK3004077T3
DK3004077T3 DK14728131.5T DK14728131T DK3004077T3 DK 3004077 T3 DK3004077 T3 DK 3004077T3 DK 14728131 T DK14728131 T DK 14728131T DK 3004077 T3 DK3004077 T3 DK 3004077T3
Authority
DK
Denmark
Prior art keywords
dihydro
isoindol
isoquinolin
compounds
new
Prior art date
Application number
DK14728131.5T
Other languages
English (en)
Inventor
Johannes Aebi
Kurt Amrein
Benoit Hornsperger
Bernd Kuhn
Hans P Maerki
Rainer E Martin
Alexander V Mayweg
Wenming Chen
Yongfu Liu
Lisha Wang
Mingwei Zhou
Xuefei Tan
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of DK3004077T3 publication Critical patent/DK3004077T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/38Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/42Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of mineralocorticosteroids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/38Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/46Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of glucocorticosteroids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK14728131.5T 2013-05-27 2014-05-26 Nye 3,4-dihydro-2H-isoquinolin-1-on- og 2,3-dihydro-isoindol-1-on-forbindelser DK3004077T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN2013076281 2013-05-27
PCT/EP2014/060790 WO2014191338A1 (en) 2013-05-27 2014-05-26 New 3,4-dihydro-2h-isoquinoline-1-one and 2,3-dihydro-isoindol-1-one compounds

Publications (1)

Publication Number Publication Date
DK3004077T3 true DK3004077T3 (da) 2020-01-13

Family

ID=50884887

Family Applications (1)

Application Number Title Priority Date Filing Date
DK14728131.5T DK3004077T3 (da) 2013-05-27 2014-05-26 Nye 3,4-dihydro-2H-isoquinolin-1-on- og 2,3-dihydro-isoindol-1-on-forbindelser

Country Status (22)

Country Link
US (1) US9695151B2 (da)
EP (1) EP3004077B1 (da)
JP (2) JP6416229B2 (da)
KR (1) KR102436885B1 (da)
CN (1) CN105143204B (da)
AR (1) AR096424A1 (da)
BR (1) BR112015028871B1 (da)
CA (1) CA2903180C (da)
DK (1) DK3004077T3 (da)
ES (1) ES2763338T3 (da)
HK (1) HK1213564A1 (da)
HR (1) HRP20192275T1 (da)
HU (1) HUE046773T2 (da)
LT (1) LT3004077T (da)
MX (1) MX370389B (da)
PL (1) PL3004077T3 (da)
PT (1) PT3004077T (da)
RS (1) RS59739B1 (da)
RU (1) RU2695524C2 (da)
SI (1) SI3004077T1 (da)
TW (1) TWI651317B (da)
WO (1) WO2014191338A1 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR096424A1 (es) * 2013-05-27 2015-12-30 Hoffmann La Roche Compuestos de 3,4-dihidro-2h-isoquinolin-1-ona y 2,3-dihidro-isoindol-1-ona
EP3054957B1 (en) 2013-10-07 2019-10-02 Antares Pharma, Inc. Hematocrit modulation through needle assisted jet injection of testosterone
CA2962122A1 (en) * 2014-10-08 2016-04-14 F. Hoffmann-La Roche Ag Spirodiamine derivatives as aldosterone synthase inhibitors
EP3732163A4 (en) 2017-12-20 2021-07-14 Vanderbilt University MUSCARINIAN ACETYLCHOLINE RECEPTOR ANTAGONISTS M4
RU2717310C1 (ru) * 2019-06-04 2020-03-20 Общество с ограниченной ответственностью "Таргет Медикалс" Ингибиторы альдостеронсинтазы на основе производных 2-амино-4H-пиран-3-карбонитрила

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4710507A (en) * 1983-12-22 1987-12-01 Pfizer Inc. Quinolone inotropic agents
CN85100796A (zh) * 1985-04-01 1986-10-01 辉瑞公司 喹啉酮衍生物的制备方法
DE102008022221A1 (de) * 2008-05-06 2009-11-12 Universität des Saarlandes Inhibitoren der humanen Aldosteronsynthase CYP11B2
US8541404B2 (en) * 2009-11-09 2013-09-24 Elexopharm Gmbh Inhibitors of the human aldosterone synthase CYP11B2
CN103108871B (zh) * 2010-09-16 2014-09-10 诺华股份有限公司 17α-羟化酶/C17,20-裂合酶抑制剂
AU2012250059A1 (en) * 2011-04-26 2013-10-10 Elexopharm Gmbh Aldosterone synthase inhibitors
PL2755963T3 (pl) 2011-09-15 2020-07-27 F. Hoffmann-La Roche Ag Nowe pochodne dihydrochinolin-2-onu
US9353081B2 (en) * 2011-09-23 2016-05-31 Hoffmann-La Roche Inc. Bicyclic dihydroquinoline-2-one derivatives
AR096424A1 (es) * 2013-05-27 2015-12-30 Hoffmann La Roche Compuestos de 3,4-dihidro-2h-isoquinolin-1-ona y 2,3-dihidro-isoindol-1-ona
ES2763424T3 (es) * 2013-05-27 2020-05-28 Hoffmann La Roche Nuevos compuestos de 3,4-dihidro-2H-isoquinolin-1-ona y 2,3-dihidro-isoindol-1-ona

Also Published As

Publication number Publication date
RU2015150287A (ru) 2017-06-28
JP2019023212A (ja) 2019-02-14
LT3004077T (lt) 2020-01-27
MX370389B (es) 2019-12-11
EP3004077B1 (en) 2019-10-30
EP3004077A1 (en) 2016-04-13
AR096424A1 (es) 2015-12-30
TWI651317B (zh) 2019-02-21
BR112015028871B1 (pt) 2022-02-01
JP6416229B2 (ja) 2018-10-31
PT3004077T (pt) 2019-12-19
WO2014191338A1 (en) 2014-12-04
TW201533037A (zh) 2015-09-01
KR20160012145A (ko) 2016-02-02
HRP20192275T1 (hr) 2020-03-06
BR112015028871A2 (pt) 2017-07-25
HUE046773T2 (hu) 2020-03-30
SI3004077T1 (sl) 2020-01-31
MX2015015010A (es) 2016-03-09
JP6670906B2 (ja) 2020-03-25
HK1213564A1 (zh) 2016-07-08
CN105143204B (zh) 2018-02-02
KR102436885B1 (ko) 2022-08-26
US20160075687A1 (en) 2016-03-17
US9695151B2 (en) 2017-07-04
PL3004077T3 (pl) 2020-04-30
JP2016520601A (ja) 2016-07-14
CA2903180A1 (en) 2014-12-04
RU2695524C2 (ru) 2019-07-23
RS59739B1 (sr) 2020-02-28
ES2763338T3 (es) 2020-05-28
CA2903180C (en) 2022-03-15
CN105143204A (zh) 2015-12-09

Similar Documents

Publication Publication Date Title
DK3038654T3 (da) Ny anvendelse
DK2970235T3 (da) Nye inhibitorer
DK3057396T3 (da) Gensåningsindretning
DK2975030T3 (da) Dihydropyridazin-3,5-dion-derivat
DK3298022T3 (da) Nye annelerede phenoxyacetamider
DK3004077T3 (da) Nye 3,4-dihydro-2H-isoquinolin-1-on- og 2,3-dihydro-isoindol-1-on-forbindelser
HK1214258A1 (zh) 新的 -二氫- -異喹啉- -酮和 -二氫-異吲哚- -酮化合物
FI20135831A (fi) Toiminnallinen vaatekappale
FR3010388B1 (fr) Machine d'impression-emballage
BR112016001617A2 (pt) dispositivo de distribuição de meio
DK3004076T3 (da) Nye 3,4-dihydro-2h-isoquinolin-1-on- og 2,3-dihydro-isoindol-1-on-forbindelser
DK2989681T3 (da) Sporingsindretning
DE202013102236U8 (de) Haltevorrichtung
ES1093855Y (es) Dispositivo porta-fichas
ES1098030Y (es) Dispositivo enfriador
ES1092430Y (es) "Anafe paellero"
FI10291U1 (fi) Tuulisuoja
ES1095830Y (es) Tejido simple.
TH149072B (th) อนุพันธ์ควิโนโลนใหม่ (novel quinolone derivatives)
UA25763S (uk) Закупорювальний пристрій
ES1090781Y (es) Garrafa térmica
ES1096705Y (es) Grada Tetrafunción
ITCE20130011U1 (it) "sciuscia' - ventaglio automativo"
FI10349U1 (fi) Tulvahälytyskokoonpano
FI10093U1 (fi) Jalusta